Echistatin
Latest Information Update: 08 Aug 2002
At a glance
- Originator Merck & Co
- Class Anti-ischaemics; Antiplatelets; Contraceptives
- Mechanism of Action Fibrinogen inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Ischaemic heart disorders; Thrombosis
Most Recent Events
- 18 Jan 1995 Phase-I clinical trials for Ischaemic heart disorders in USA (Unknown route)